-
For your smoking cessation programs to be successful, there are two things you should address, according to new research from Indiana University (IU).
-
Employees with chronic conditions that put them at risk for high health care costs but don't fall into traditional disease management programs are learning how to manage their conditions through the ComplexCare program from Health Management Corp.
-
-
The Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial began in 1986, enrolling 2,471 women with a positive first-degree family history of breast cancer.1 The treatment group received 20 mg tamoxifen daily for 8 years.
-
The author reviewed a year's worth of data from a busy hospital in France where manual rotation was liberally used. The procedure, which will be described below, was used in 796 patients, in whom 85 (9.7%) failed.
-
Germline mutations in BRCA1 or BRCA2 associated with the Hereditary Breast/Ovarian Cancer syndrome have an increased lifetime risk for breast (up to 85%) and ovarian (up to 46% BRCA1, up to 27% BRCA2) cancer.
-
A team of epidemiologists from several institutions in the US performed a case-control study of the association between oral contraceptive use and lobular and ductal breast cancer occurring in young women (under age 44).
-
-
-
Wilkinson and colleagues from the University of Texas in Galveston analyzed information from the Surveillance, Epidemiology, and End Results (SEER) databank linked to Medicare claims.
